For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene [...]
Induced pluripotent stem cells (iPSCs) hold great value in research because of their unique ability to differentiate into various cell types. These cells offer a [...]
Gene editing technologies have revolutionized the field of molecular biology, offering powerful tools to modify DNA with precision. Two primary categories of gene editing methodologies [...]
Gene editing technologies like transcription activator-like effector nucleases (TALEN), zinc finger nucleases (ZFN), CRISPR-Cas systems, base editors, and prime editors, among others, have become essential [...]
